TransMedics Group Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.3% | 10.2% | -3.5% | 22.5% | 6.3% | 16.2% | -2.0% | 58.2% | 48.4% | 21.5% | 14.1% | 9.1% | 21.8% | |
| 2.8% | 4.6% | 4.5% | 4.0% | 4.8% | 4.7% | 4.3% | 4.3% | 4.8% | 4.6% | 6.8% | 5.4% | 5.4% | |
| 7.8% | 7.1% | 7.1% | 6.7% | 7.3% | 8.9% | 6.2% | 6.0% | 6.4% | 5.8% | 5.7% | 4.5% | 5.5% | |
| -23.4% | -6.8% | -29.0% | 0.2% | -10.3% | -4.8% | -30.9% | 25.5% | 19.4% | -3.1% | -6.5% | -13.4% | -2.1% | |
| 162.2% | 51.5% | 45.6% | 20.8% | 44.3% | 11.2% | 18.8% | 5.8% | 5.3% | 9.7% | 21.1% | 3.7% | 10.0% | |
| -225.5% | -51.5% | -45.6% | -20.8% | -43.9% | -11.2% | -18.8% | -5.8% | -5.3% | -9.7% | -21.1% | -3.7% | -10.0% | |
| – | 0.7% | 0.7% | – | 1.3% | – | – | 0.8% | 1.4% | – | 1.0% | 0.0% | – | |
| – | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 2.3% | 1.1% | 3.3% | 9.3% | 7.2% | 1.0% | 2.1% | 4.5% | 2.5% | 1.9% | 2.2% | 0.5% | 1.7% | |
| -233.5% | -39.8% | -46.0% | 11.0% | -30.0% | 5.4% | -18.5% | 57.5% | 45.6% | 13.8% | -5.0% | 5.8% | 13.5% | |
| -172.5% | -41.3% | -49.2% | 1.7% | -38.0% | 5.0% | -20.8% | 52.4% | 43.1% | 11.8% | -7.0% | 5.4% | 11.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.